Markus Falk

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Tyrosine Kinase

Circulating Tumor

Small Cell Lung Cancer

Top Venues

Current oncology (Toronto, Ont.)

Translational lung cancer research

Virchows Archiv : an international journal of pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Balázs Jóri, Otto Bundschuh, Markus Falk, Lukas C Heukamp, Alexander Kluge, Markus Tiemann, Kay C Willborn, Johannes Woitzik, Frank Griesinger
Intracranial response to capmatinib after progression on crizotinib in a patient with MET exon 14 skipping non-small cell lung cancer-a case report. Translational lung cancer research 13 (7) (2024)
Balázs Jóri, Otto Bundschuh, Markus Falk, Lukas C Heukamp, Alexander Kluge, Markus Tiemann, Kay C Willborn, Johannes Woitzik, Frank Griesinger
Intracranial response to capmatinib after progression on crizotinib in a patient with MET exon 14 skipping non-small cell lung cancer-a case report. Translational lung cancer research 13 (7) (2024)
Markus Falk, Eva Willing, Stefanie Schmidt, Stefanie Schatz, Marco Galster, Markus Tiemann, Joachim H Ficker, Wolfgang M Brückl
Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy. Current oncology (Toronto, Ont.) 30 (2) (2023)
Eva Maria Willing, Claudia Vollbrecht, Christine Vössing, Peggy Weist, Simon Schallenberg, Johanna M Herbst, Stefanie Schatz, Balázs Jóri, Guillaume Bataillon, Philipp Harter, Vanda Salutari, Antonio Gonzáles Martin, Ignace Vergote, Nicoletta Colombo, Julia Roeper, Tobias Berg, Regina Berger, Bettina Kah, Trine Jakobi Noettrup, Markus Falk, Kathrin Arndt, Andreas Polten, Isabelle L Ray-Coquard, Franziska Selzam, Judith Pirngruber, Stefanie Schmidt, Michael Hummel, Markus Tiemann, David Horst, Jalid Sehouli, Eric Pujade-Lauraine, Katharina Tiemann, Elena Ioana Braicu, Lukas C Heukamp
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation. Cancers 15 (13) (2023)
Balázs Jóri, Christine Vössing, Judith Pirngruber, Eva Maria Willing, Kathrin Arndt, Markus Falk, Markus Tiemann, Lukas C Heukamp, Petra Hoffknecht
The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations. Current oncology (Toronto, Ont.) 30 (10) (2023)
Markus Falk, Eva Willing, Stefanie Schmidt, Stefanie Schatz, Marco Galster, Markus Tiemann, Joachim H Ficker, Wolfgang M Brückl
Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy. Current oncology (Toronto, Ont.) 30 (2) (2023)
Markus Falk, Eva Willing, Stefanie Schmidt, Stefanie Schatz, Marco Galster, Markus Tiemann, Joachim H Ficker, Wolfgang M Brückl
Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy. Current oncology (Toronto, Ont.) 30 (2) (2023)
Markus Falk, Eva Willing, Stefanie Schmidt, Stefanie Schatz, Marco Galster, Markus Tiemann, Joachim H Ficker, Wolfgang M Brückl
Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy. Current oncology (Toronto, Ont.) 30 (2) (2023)
Markus Falk, Eva Willing, Stefanie Schmidt, Stefanie Schatz, Marco Galster, Markus Tiemann, Joachim H Ficker, Wolfgang M Brückl
Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy. Current oncology (Toronto, Ont.) 30 (2) (2023)
Markus Falk, Stefanie Schatz, Fabian P M Reich, Stefanie Schmidt, Marco Galster, Markus Tiemann, Joachim H Ficker, Wolfgang M Brückl
Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case Report. Current oncology (Toronto, Ont.) 30 (10) (2023)
Markus Falk, Eva Willing, Stefanie Schmidt, Stefanie Schatz, Marco Galster, Markus Tiemann, Joachim H Ficker, Wolfgang M Brückl
Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy. Current oncology (Toronto, Ont.) 30 (2) (2023)
Balázs Jóri, Markus Falk, Iris Hövel, Peggy Weist, Markus Tiemann, Lukas C Heukamp, Frank Griesinger
Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy. Current oncology (Toronto, Ont.) 29 (9) (2022)
André Fehr, Sarah Werenicz, Pietro Trocchi, Markus Falk, Reinhard E Friedrich, Angelika Stammler, Andreas Stang, Florian Oesterling, Laura Khil, Göran Stenman, Werner Böcker, Katharina Tiemann, Thomas Löning
Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping. Virchows Archiv : an international journal of pathology 479 (5) (2021)
Balázs Jóri, Stefanie Schatz, Len Kaller, Bettina Kah, Julia Roeper, Hayat O Ramdani, Linda Diehl, Petra Hoffknecht, Christian Grohé, Frank Griesinger, Markus Tiemann, Lukas C Heukamp, Markus Falk
Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy. Cancers 13 (12) (2021)